Delhivery Limited has informed the Exchange regarding Outcome of Board Meeting held on May 16, 2025.

Emphasis of matterExceptional itemProfit growth above 25%Results View source PDF Explain this filing

DELHIVERY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+10.1%Reaction day

₹321.10

prior close

₹335.85

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.7%+9.4% vs market

Logistics Solution Provider peers, median of 39sector+0.7%+9.4% vs sector

On the reaction day the stock moved 9.4 pts more than Nifty Smallcap 250 and 9.4 pts more than its Logistics Solution Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.0

10m

+1.8

15m

+2.5

30m

+4.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+10.1+0.7+9.4+0.7+9.4

Next day

+9.0-0.2+9.2-0.4+9.4

+8.4+0.2+8.2-0.6+9.0

+9.2+0.2+9.0+0.2+9.0

+10.2+0.8+9.4+0.4+9.8

+13.0+1.3+11.7+1.6+11.5

+11.7+1.8+9.9+1.0+10.7

15d

+15.9+6.8+9.1+4.7+11.1

+10.1+2.5+7.6-0.5+10.6

+34.6+9.0+25.6+7.2+27.3

+47.3+3.7+43.6-2.0+49.3

UpDownMarket · Nifty Smallcap 250Sector · Logistics Solution Provider peers, median of 39Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Delhivery's board approved audited consolidated and standalone results for Q4 FY25 and full-year FY25 on May 16, 2025. Full-year revenue from contracts with customers rose to Rs. 89,319.01 million from Rs. 81,415.38 million, a growth of about 10% year-on-year. The company swung to a consolidated profit of Rs. 1,621.10 million in FY25, compared to a loss of Rs. 2,491.86 million in FY24, with basic EPS of Rs. 2.19 versus Rs. (3.40) last year. Q4 FY25 also turned profitable at Rs. 725.57 million versus a loss of Rs. 684.68 million in Q4 FY24. Operating cash flow improved to Rs. 5,673.63 million. Statutory auditor Deloitte Haskins & Sells issued an unmodified opinion, but flagged an Emphasis of Matter regarding the accounting treatment of goodwill from the Spoton–Venkatesh Pharma amalgamation scheme. The company also highlighted the recently approved acquisition of Ecom Express for up to Rs. 14,070 million and a change in depreciation method to straight-line which lowered depreciation expense by Rs. 2,289.78 million for the year.

Likely market impact

Strong turnaround story for shareholders with the company returning to profit at both quarterly and annual levels, revenue growth near 10%, and robust operating cash flows. The pending Ecom Express acquisition could materially expand scale but will use significant cash, and the depreciation method change boosted reported earnings. Investors should note the auditor's emphasis-of-matter paragraph, though it does not modify the clean audit opinion.